Search by Drug Name or NDC
NDC 70121-1397-07 Glycopyrrolate 4 mg/20mL Details
Glycopyrrolate 4 mg/20mL
Glycopyrrolate is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is GLYCOPYRROLATE.
Product Information
| NDC | 70121-1397 |
|---|---|
| Product ID | 70121-1397_c891516f-2a9d-4020-986e-5a741fa4e38b |
| Associated GPIs | 49102030002014 |
| GCN Sequence Number | 004886 |
| GCN Sequence Number Description | glycopyrrolate VIAL 0.2 MG/ML INJECTION |
| HIC3 | J2B |
| HIC3 Description | ANTICHOLINERGICS,QUATERNARY AMMONIUM |
| GCN | 19121 |
| HICL Sequence Number | 002028 |
| HICL Sequence Number Description | GLYCOPYRROLATE |
| Brand/Generic | Generic |
| Proprietary Name | Glycopyrrolate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Glycopyrrolate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/20mL |
| Substance Name | GLYCOPYRROLATE |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208973 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70121-1397-07 (70121139707)
| NDC Package Code | 70121-1397-7 |
|---|---|
| Billing NDC | 70121139707 |
| Package | 10 VIAL in 1 CARTON (70121-1397-7) / 20 mL in 1 VIAL (70121-1397-1) |
| Marketing Start Date | 2017-06-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |